Clinical trial
Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)
NCT06928415 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)
- Lead sponsor
- Zhejiang University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 10, 2025
- Completion date
- January 10, 2029
- Enrollment
- 130 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bile duct tumor thrombus, hepatocellular carcinoma, liver transplant